KR L
PI L

AC EL
CA TA

Cannabis Investment Report | December 2017

= Cannabinoids

Cannabinoids are compounds present in the cannabis plant that act on human cannabinoid receptors
in cells in the nervous and immune systems. Scientists have identified more than 100 cannabinoids in
the cannabis plant. Generally, the most abundant cannabinoid is THC, a psychoactive compound that
causes a euphoric “high,” and the second most abundant cannabinoid is cannabidiol, or CBD, which
produces a relaxing physical effect without a psychoactive effect. Consuming cannabinoids has been
shown to have numerous medicinal benefits and therapeutic applications. The following table lists

20 common conditions for which medical cannabis use has been legalized under U.S. state laws and
identifies 8 cannabinoids that are used or being studied to treat these conditions. A brief description of
these cannabinoids follows the table.

Common Qualifying Medical Conditions and Potentially Therapeutic Cannabinoids
e e

Alzheimer's disease

Amyotrophic lateral sclerosis (ALS)
Anorexia

Arthritis

Cachexia

Cancer

Chronic pain

Crohn's disease e
Epilepsy
Glaucoma
Hepatitis C
HIV/AIDS e
Inflammation

Migraine e
Multiple sclerosis e
Nausea e
Nervous system degeneration

Parkinson's disease

Post-traumatic stress disorder (PTSD)
Spasms e

THC  Tetrahydrocannabinol: THC refers to delta-9-tetrahydrocannabinol and certain chemical
variants, including delta-8-tetrahydrocannabinol. THC is the most abundant cannabinoid in cannabis
and is understood to be the psychoactive compound in cannabis primarily responsible for the euphoric
feeling of being “high.” Both recreational and medicinal users often seek the psychoactive effects of
THC and may prefer certain cannabis products based solely on the quality and level of THC. THC
is believed to have wide-ranging medicinal benefits: analgesic, antianxiety, antibacterial, anticancer,

20 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC

HOUSE_OVERSIGHT_024656
